Literature DB >> 32151626

Hidradenitis suppurativa management using tumor necrosis factor inhibitors in patients younger than 18 years: A series of 12 cases.

Anne-Claire Fougerousse1, Ziad Reguiai2, Aude Roussel3, Pierre-André Bécherel4.   

Abstract

Entities:  

Year:  2020        PMID： 32151626     DOI： 10.1016/j.jaad.2020.02.071

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

1.  Efficacy and safety of adalimumab in hidradenitis suppurativa: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Jing-Wun Lu; Yu-Wen Huang; Tai-Li Chen
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

Review 2.  Infliximab in hidradenitis suppurativa: A systematic review and meta-analysis.

Authors:  Terri Shih; Katrina Lee; Tristan Grogan; Devea R De; Vivian Y Shi; Jennifer L Hsiao
Journal:  Dermatol Ther       Date:  2022-07-18       Impact factor: 3.858

3.  Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review.

Authors:  Muskaan Sachdeva; Patrick Kim; Asfandyar Mufti; Khalad Maliyar; Cathryn Sibbald; Afsaneh Alavi
Journal:  J Cutan Med Surg       Date:  2021-09-29       Impact factor: 2.092
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.